Amanote Research
Register
Sign In
New Therapies of Neovascular AMD &Ndash; Beyond Anti VEGFs
doi 10.20944/preprints201806.0168.v1
Full Text
Open PDF
Abstract
Available in
full text
Date
June 12, 2018
Authors
Praveen Yerramothu
Publisher
MDPI AG
Related search
Anti-Vascular Therapies in Ovarian Cancer: Moving Beyond Anti-Vegf Approaches
Cancer and Metastasis Reviews
Cancer Research
Oncology
Incidence of Ocular Hypertension After Intravitreal Injection of Anti-Vegf Agents in the Treatment of Neovascular AMD
Romanian journal of ophthalmology
Medicine
Re-Treatment Strategies for Neovascular AMD: When to Treat? When to Stop?
Determinants of Visual Acuity Outcomes in Eyes With Neovascular AMD Treated With Anti-Vegf Agents: An Instrumental Variable Analysis of the AURA Study
Eye
Medicine
Arts
Sensory Systems
Ophthalmology
Humanities
Retinal Vascular Changes Following Intravitreal Ranibizumab Injections for Neovascular AMD Over a 1-Year Period
Eye
Medicine
Arts
Sensory Systems
Ophthalmology
Humanities
Anti-Vascular Endothelial Growth Factor for Neovascular Glaucoma
Cochrane Database of Systematic Reviews
Kilovoltage Radiosurgery With Gold Nanoparticles for Neovascular Age-Related Macular Degeneration (AMD): A Monte Carlo Evaluation
Physics in Medicine and Biology
Radiological
Radiology
Nuclear Medicine
Ultrasound Technology
Imaging
Emerging Targeted Therapies for Plaque Psoriasis &Ndash; Impact of Ixekizumab
Clinical, Cosmetic and Investigational Dermatology
Dermatology
Disease-Modifying Therapies in Relapsing–remitting Multiple Sclerosis
Neuropsychiatric Disease and Treatment
Psychiatry
Mental Health
Biological Psychiatry
